More Americans Are Now Dying at Home

WEDNESDAY, Dec. 11, 2019 — Most folks would prefer a peaceful death at home, in familiar surroundings with the company of their loved ones. Now, for the first time in a century, there’s a rise in the likelihood of those dying wishes to be honored. Home has now surpassed the hospital as the most common […]

Continue Reading

Rural Seniors Hurt by Lack of Medical Specialists

WEDNESDAY, Dec. 11, 2019 — American seniors living in rural areas face a higher risk of hospitalization and death, and a lack of medical specialists may be the reason why, researchers report. “People on Medicare with chronic conditions such as heart failure or diabetes who live in rural areas have higher death and hospitalization rates […]

Continue Reading

Trastuzumab deruxtecan achieved a tumour response rate of 60.9% in pivotal Phase II HER2-positive metastatic breast cancer trial

AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo) today presented positive detailed data from the global pivotal Phase II single-arm DESTINY-Breast01 trial of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody drug conjugate (ADC) and potential new medicine, in patients with HER2-positive metastatic breast cancer who received two or more prior HER2-targeted regimens. The primary endpoint of […]

Continue Reading